16 Feb 2018 07:00
Realm Therapeutics plc
Block Listing Interim Review
Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Realm Therapeutics plc makes the following update on its block listing:
Date: 16 February 2018
Name of applicant: | Realm Therapeutics plc | |
Name of scheme: | Executive Omnibus Incentive Plan | Warrants |
Figures for all schemes relate to ordinary shares of 10 pence each | ||
Period of return: | From: 18 August 2017 To: 15 February 2018 | |
Balance of unallotted securities under scheme(s) from previous return: | 2,055,362 | 117,195 |
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | 21,139,826 |
Less: Number of securities issued/allotted under scheme(s) during period: | Nil | Nil |
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2,055,362 | 21,257,021 |
Number and class of securities originally admitted:* these securities have been adjusted for a 1 for 10 share consolidation which took effect on 2 July 2010 | *20,000 and *378,423 + *32,000 and 200,000 | *196,087 and *21,108 |
Dates of Admission: | 7 August 2006 and 31 August 2007 and 15 August 2012 | 7 August 2006 and 31 August 2007 |
Name of contact: | Marella Thorell, Company Secretary | |
Telephone number of contact: | +1 484-321-2749 | |
RLM.L (RLM)